Bachem (OTCMKTS:BCHMF – Get Free Report) and Aspen Aerogels (NYSE:ASPN – Get Free Report) are both materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Analyst Ratings
This is a summary of current ratings and price targets for Bachem and Aspen Aerogels, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Bachem | 1 | 0 | 3 | 0 | 2.50 |
| Aspen Aerogels | 2 | 1 | 4 | 0 | 2.29 |
Aspen Aerogels has a consensus price target of $5.94, indicating a potential upside of 13.96%. Given Aspen Aerogels’ higher probable upside, analysts clearly believe Aspen Aerogels is more favorable than Bachem.
Earnings & Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Bachem | N/A | N/A | N/A | N/A | N/A |
| Aspen Aerogels | $271.10 million | 1.59 | -$389.55 million | ($1.53) | -3.41 |
Bachem has higher earnings, but lower revenue than Aspen Aerogels.
Insider & Institutional Ownership
97.6% of Aspen Aerogels shares are owned by institutional investors. 3.0% of Aspen Aerogels shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Profitability
This table compares Bachem and Aspen Aerogels’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Bachem | N/A | N/A | N/A |
| Aspen Aerogels | -62.45% | -31.12% | -17.33% |
Summary
Aspen Aerogels beats Bachem on 5 of the 9 factors compared between the two stocks.
About Bachem
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.
About Aspen Aerogels
Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; and Pyrogel HPS for applications within the power generation market. It also offers Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.
Receive News & Ratings for Bachem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bachem and related companies with MarketBeat.com's FREE daily email newsletter.
